Ethnic Disparities in Chronic Hepatitis B Infection: African Americans and Hispanic Americans

被引:21
作者
Kimberly A. Forde
机构
[1] Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 722 Blockley Hall, 423 Guardian Drive, Philadelphia, 19104-6021, PA
[2] Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
关键词
African Americans; Chronic infection; Disparities; Hepatitis B; Hispanics;
D O I
10.1007/s11901-017-0348-8
中图分类号
学科分类号
摘要
Purpose of Review: Chronic infection with hepatitis B affects more than 240 million persons worldwide and is a major public health concern. Despite national and global initiatives to promote hepatitis B elimination, including newborn vaccination, catch-up vaccination in adolescents and high-risk adults, screening of the blood supply, and treatment of those in need, both new infections and a reservoir of chronic infections continue to result in morbidity and mortality. As with many chronic diseases, racial and ethnic disparities are seen in hepatitis B virus infection. The goal of this review is to synthesize the data concerning the burden of hepatitis B infection in African Americans and Hispanics, two racial/ethnic groups in the United States who encounter barriers in access to care, low engagement in care, and low utilization of diagnostic and treatment services. Recent Findings: Recent data, though sparse in certain areas, continue to suggest differences in rates of incidence and prevalence of hepatitis B virus infection in African Americans, and differences in screening, specialty referral and initiation of therapy for African Americans and Hispanics. Data are lacking about differences in liver disease progression and manifestations in both African Americans and Hispanics. Summary: Disparities in hepatitis B diagnosis, disease management, treatment, and prevention remain for African Americans and Hispanics. These disparities require a commitment from governmental and public health organizations. The efforts should include increasing vaccination in those most susceptible to infection, screening those at highest risk for infection, initiating antiviral therapy in those who require it, and monitoring for liver-related complications, such as decompensated cirrhosis and hepatocellular carcinoma in the chronically infected. This multipronged approach is necessary to realize hepatitis B elimination. © Springer Science+Business Media New York 2017.
引用
收藏
页码:105 / 112
页数:7
相关论文
共 49 条
[1]  
Hepatitis B fact sheet, (2016)
[2]  
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 385, 9963, pp. 117-171, (2015)
[3]  
Global Health Sector Strategy on Viral Hepatitis 2016–2021, (2016)
[4]  
Transforming our world: The 2030 agenda for sustainable development, Seventieth United Nations General Assembly, (2016)
[5]  
Wasley A., Kruszon-Moran D., Kuhnert W., Simard E.P., Finelli L., McQuillan G., Et al., The prevalence of hepatitis B virus infection in the United States in the era of vaccination, J Infect Dis, 202, 2, pp. 192-201, (2010)
[6]  
Ioannou G.N., Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey, Ann Intern Med, 154, 5, pp. 319-328, (2011)
[7]  
Kowdley K.V., Wang C.C., Welch S., Roberts H., Brosgart C.L., Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin, Hepatology, 56, 2, pp. 422-433, (2012)
[8]  
Roberts H., Kruszon-Moran D., Ly K.N., Hughes E., Iqbal K., Jiles R.B., Et al., Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988–2012, Hepatology, 63, 2, pp. 388-397, (2016)
[9]  
Buckley G.J., Strom B.L., A national strategy for the elimination of viral hepatitis emphasizes prevention, screening, and universal treatment of hepatitis C, Ann Intern Med, (2017)
[10]  
Recommendations of the Immunization Practices Advisory Committee (ACIP), MMWR Recomm Rep, 40, pp. 1-25, (1991)